SHPT (PTH > 65 pg/mL) affects approximately 40% of patients with CKD stage G3 (with the percentage rising from stage G3a–G3b), rising to approximately 80% in CKD stage G4 [14]. The gene discussed is PTH; the disease is chronic kidney disease.